Top of page Skip navigation

Day One |13 July 2020

12.30  Registration 

13:30  Welcome

13:45  Keynote Speakers
Whether it’s the rise of precision medicine or the increase of technology components in healthcare delivery these presentations will review their impact on Research and Development in the pharmaceutical industry.

Opening panel discussion - Transforming R&D with Patients
The patients we’re all are, are invaluable resources to improve the way we approach R&D. This session should highlight some examples of this and how patients are getting back at the heart of R&D.

15:30  Tea/Coffee Break

16:00 Transforming Drugs with Diagnostics – Plenary Session
With the promise for earlier interventions and better patients’ segmentation, diagnostics have the potential to disturb the way therapeutics are delivered. This session will showcase three examples of diagnostics influence in therapeutics drug development.

16:00  Workshop - Thinking medical communication early enough. For your investors, collaborators and own interest.

17:00  Cambridge Biotech: Back to the Future II

Nick McCooke

18:15  Drinks Reception

19:30 Close

 

Day Two |14 July 2020

08:30  Registration

08:55  Welcome back

09:00  Keynote speaker
A case study of a successful new modality drug development.

Akshay Vaishnaw, President Research and Development Alnylam

Panel Discussion – The Business Models of Research 
New modalities, sophistication of data health claims, global and more complex markets, pharmas business models are evolving but what about their R&D models? What will be key to lead tomorrow’s therapeutics development? This panel session will discuss some elements of answer on:

  • Strategic approaches in therapeutic areas from niche to cross indications
  • The specialisation in technologies elements and how data is taking a leading role in R&D

10:15  Tea/Coffee Break

10:45  Unlocking the Undruggable Space – Plenary Session
A session to review current limitations in targets addressed and presentations on solutions to unlock them.

Benedict Cross, Phoremost

10:45  Workshop - Facilities to support growth

11:45  Surpassing Current pre-clinical Models – Plenary Session
A session to review the current progresses and limitations of innovative pre-clinical models.

11:45  Workshop - PMultidisciplinarity vs Expertise - the 21st century scientist

12:45 – Lunch

13:45  Manufacturing New Modalities – Plenary Session
A session to review what will be needed to shift paradigm in therapeutics development especially in the cell and gene therapy space

13:45  Workshop - Early stage research – what public funding is available and how to access it.

14:45  Backing Health Claims in a Sophisticated Therapeutics Game – Plenary Session
With a more diverse and costly pool of therapeutics, how to build more robust evidence to back health claim for regulatory, payers and patients.

14:45  Workshop - Your pre-clinical dataset in a nutshell

15:45  Tea/Coffee Break

16:15  Closing panel – Who Will Lead the Future of New Modalities?
We’re seeing an increasing fight for acquisition from pharma and service companies to lead next generation therapeutics development, this panel will review some of these big deals and how they may impact the industry.


Please contact aline@onenucleus.com with any questions regarding the 2020 programme